GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aurora Spine Corp (OTCPK:ASAPF) » Definitions » Cyclically Adjusted Revenue per Share

ASAPF (Aurora Spine) Cyclically Adjusted Revenue per Share : $0.22 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Aurora Spine Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Aurora Spine's adjusted revenue per share for the three months ended in Dec. 2024 was $0.060. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.22 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Aurora Spine's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-05-13), Aurora Spine's current stock price is $0.22. Aurora Spine's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was $0.22. Aurora Spine's Cyclically Adjusted PS Ratio of today is 1.00.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Aurora Spine was 1.74. The lowest was 0.85. And the median was 1.16.


Aurora Spine Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Aurora Spine's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Spine Cyclically Adjusted Revenue per Share Chart

Aurora Spine Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.20 0.21 0.22

Aurora Spine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.19 0.20 0.23 0.22

Competitive Comparison of Aurora Spine's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Aurora Spine's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurora Spine's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Aurora Spine's Cyclically Adjusted PS Ratio falls into.


;
;

Aurora Spine Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aurora Spine's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.06/127.3637*127.3637
=0.060

Current CPI (Dec. 2024) = 127.3637.

Aurora Spine Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.055 99.789 0.070
201506 0.043 100.500 0.054
201509 0.038 100.421 0.048
201512 0.050 99.947 0.064
201603 0.050 101.054 0.063
201606 0.057 102.002 0.071
201609 0.062 101.765 0.078
201612 0.065 101.449 0.082
201703 0.046 102.634 0.057
201706 0.041 103.029 0.051
201709 0.051 103.345 0.063
201712 0.036 103.345 0.044
201803 0.036 105.004 0.044
201806 0.044 105.557 0.053
201809 0.059 105.636 0.071
201812 0.054 105.399 0.065
201903 0.059 106.979 0.070
201906 0.070 107.690 0.083
201909 0.061 107.611 0.072
201912 0.057 107.769 0.067
202003 0.043 107.927 0.051
202006 0.029 108.401 0.034
202009 0.043 108.164 0.051
202012 0.044 108.559 0.052
202103 0.041 110.298 0.047
202106 0.035 111.720 0.040
202109 0.043 112.905 0.049
202112 0.044 113.774 0.049
202203 0.053 117.646 0.057
202206 0.061 120.806 0.064
202209 0.055 120.648 0.058
202212 0.054 120.964 0.057
202303 0.043 122.702 0.045
202306 0.052 124.203 0.053
202309 0.057 125.230 0.058
202312 0.054 125.072 0.055
202403 0.052 126.258 0.052
202406 0.053 127.522 0.053
202409 0.062 127.285 0.062
202412 0.060 127.364 0.060

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Aurora Spine  (OTCPK:ASAPF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Aurora Spine's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.22/0.22
=1.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Aurora Spine was 1.74. The lowest was 0.85. And the median was 1.16.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Aurora Spine Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Aurora Spine's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurora Spine Business Description

Traded in Other Exchanges
Address
20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the business of the development and commercialization of minimally invasive interspinous fusion systems and devices. The product portfolio includes implants, surgical tools, and biologics. It derives revenues primarily from the sale of spinal surgery implants, consumable products used in spinal surgeries, and service revenue for referring products to its customers.

Aurora Spine Headlines

From GuruFocus

Q2 2023 Aurora Spine Corp Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2023 Aurora Spine Corp Earnings Call Transcript

By GuruFocus Research 02-12-2024